Cathy Burgess will speak on the panel “Responding to the Latest FDA Inspection and Enforcement Activity” at this two-day event hosted by the American Conference Institute.
Cathy and the panelists will discuss:
- Investigating recent trends in OTC drug manufacturing inspections
- Shedding light on the latest areas of focus for FDA enforcement
- Examining the latest wave of FDA warning letters issued to OTC drug manufacturers regarding GMP issues – what trends are we seeing and what are the implications?
- Examining the role of compliance and ingredient transparency in shaping OTC products’ market presence
For more information, click here.